Versant Capital Management’s Idexx Laboratories IDXX Stock Holding History

Versant Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$534K	Buy	1,014 +320	+46%	+$179K	0.05%	262
2026 Q1	$390K	Buy	694 +308	+80%	+$198K	0.04%	345
2025 Q4	$261K	Sell	386 -183	-32%	-$125K	0.03%	410
2025 Q3	$364K	Buy	569 +405	+247%	+$246K	0.05%	301
2025 Q2	$88K	Buy	+164	New	+$78.4K	0.01%	729
2025 Q1	–	Sell	-21	Closed	-$8.68K	–	2569
2024 Q4	$8.68K	Sell	21 -78	-79%	-$34.2K	﹤0.01%	1483
2024 Q3	$50K	Buy	99 +70	+241%	+$34K	0.01%	451
2024 Q2	$14.1K	Buy	29 +14	+93%	+$7.03K	﹤0.01%	843
2024 Q1	$8.1K	Hold	15	–	–	﹤0.01%	858
2023 Q4	$8.33K	Buy	15 +1	+7%	+$469	﹤0.01%	803
2023 Q3	$6.12K	Sell	14 -1	-7%	-$499	﹤0.01%	901
2023 Q2	$7.53K	Buy	15 +6	+67%	+$2.88K	﹤0.01%	878
2023 Q1	$4.49K	Hold	9	–	–	﹤0.01%	979
2022 Q4	$3.67K	Buy	9 +2	+29%	+$776	﹤0.01%	982
2022 Q3	$2K	Hold	7	–	–	﹤0.01%	1084
2022 Q2	$2K	Hold	7	–	–	﹤0.01%	1102
2022 Q1	$4K	Hold	7	–	–	﹤0.01%	951
2021 Q4	$5K	Hold	7	–	–	﹤0.01%	898
2021 Q3	$4K	Hold	7	–	–	﹤0.01%	957
2021 Q2	$4K	Hold	7	–	–	﹤0.01%	963
2021 Q1	$3K	Hold	7	–	–	﹤0.01%	1155
2020 Q4	$3K	Hold	7	–	–	﹤0.01%	1047
2020 Q3	$2K	Hold	7	–	–	﹤0.01%	1069
2020 Q2	$2K	Hold	7	–	–	﹤0.01%	1060
2020 Q1	$1K	Sell	7 -16	-70%	-$4.18K	﹤0.01%	1156
2019 Q4	$6K	Hold	23	–	–	﹤0.01%	879
2019 Q3	$6K	Sell	23 -2	-8%	-$557	﹤0.01%	895
2019 Q2	$6K	Sell	25 -18	-42%	-$4.43K	﹤0.01%	907
2019 Q1	$9K	Hold	43	–	–	﹤0.01%	932
2018 Q4	$7K	Hold	43	–	–	﹤0.01%	931
2018 Q3	$10K	Sell	43 -5	-10%	-$1.21K	﹤0.01%	894
2018 Q2	$10K	Hold	48	–	–	﹤0.01%	886
2018 Q1	$9K	Hold	48	–	–	﹤0.01%	917
2017 Q4	$7K	Buy	48 +15	+45%	+$2.36K	﹤0.01%	1030
2017 Q3	$5K	Hold	33	–	–	﹤0.01%	1052
2017 Q2	$5K	Hold	33	–	–	﹤0.01%	1051
2017 Q1	$5K	Hold	33	–	–	﹤0.01%	1044
2016 Q4	$3K	Buy	33 +11	+50%	+$1.25K	﹤0.01%	1121
2016 Q3	$2K	Hold	22	–	–	﹤0.01%	1178
2016 Q2	$2K	Buy	22 +6	+38%	+$515	﹤0.01%	1143
2016 Q1	$1K	Hold	16	–	–	﹤0.01%	1237
2015 Q4	$1K	Buy	+16	New	+$1.14K	﹤0.01%	1237

Other funds holding IDXX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $538M AUM 13.79% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Versant Capital Management's IDXX Position: Q2 2026 in Review

Versant Capital Management increased its Idexx Laboratories (IDXX) stake by 46% in Q2 2026, buying an estimated $179K and bringing the position to 1,014 shares worth $534K. The position accounts for 0.05% of the portfolio, ranked #262.

Versant Capital Management first reported a position in IDXX in Q4 2015 and has held it in 42 quarters since. 205 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Versant Capital Management held 1,014 shares of Idexx Laboratories worth $534K as of Q2 2026.
Versant Capital Management bought 320 Idexx Laboratories shares in Q2 2026, an estimated $179K.
Idexx Laboratories made up 0.05% of Versant Capital Management's portfolio in Q2 2026, its #262 holding.
Versant Capital Management first reported a position in Idexx Laboratories in Q4 2015 and has held it in 42 quarters since.
205 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.